Myorythm 100 mg & 200 mg Tablets.
PDF Leaflet Revision Date: 14 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of tachydysrhythmias.
Dosage (summary)
Initial: 200 mg TID for 1 week, then 200 mg BID for 1 week, followed by 200 mg daily.
Onset of Action / Duration
Onset: 1 week, Duration: variable.
Special Populations
- Elderly
- Paediatric patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Beta-blockers
- Calcium channel inhibitors
- Sofosbuvir
Contraindications
- Hypersensitivity to amiodarone
- Sinus bradycardia
- Thyroid dysfunction
- Pregnancy
- Lactation
Common side effects
- Bradycardia
- QT prolongation
- Pulmonary toxicity
- Hepatic injury
Counselling Points
- Monitor for bradycardia
- Avoid sun exposure
- Regular liver function tests
Serious warnings
- Serious adverse reactions possible
- Pro-dysrhythmic effects
- Monitor thyroid function
Important Disclaimer
The Myorythm 100 mg & 200 mg Tablets. professional information leaflet below is the property of Ipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
